Since Phosphatase of regenerating liver (PRL)-3 is upregulated in response to IL-6 and other growth factors in MM cells [9], we have hypothesized that PRL-3 could be a downstream intersection where signals from several external growth factors converge, and possibly be a better treatment target. Here, PTP4A3 is linked to Miyoshi myopathy.